A Gene Therapy Study in Patients With Gaucher Disease Type 1

NCT05324943 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Spur Therapeutics